Biopharmaceutical company (subsidiary)
Appears in 1 story · Last updated Oct 1, 2026
As of October 2026: Leading global development of brogidirsen
Six boys with Duchenne muscular dystrophy have taken weekly doses of brogidirsen for five years. New data presented at the World Muscle Society congress in Hiroshima shows their motor function held steady and no serious side effects appeared.
Updated Oct 1
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
